| VADADUSTAT | None | ||
| 150MG, 300MG, 450MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| VAFSEO is a hypoxia-inducible factor prolyl hydroxylase (HIF PH) inhibitor indicated for the treatment of anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least three months. | |||
|
Yes
| |||
| VAFSEO | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||||
| ****** *********** ********** *** ******* ** *** | ****** *********** ********** *** ******* ** *** | ****** *********** ********** *** ******* ** *** | ****** *********** ********** *** ******* ** *** | ****** *********** ********** *** ******* ** *** | ***** ***** ** {[*-(*-************)-*-***************-*-********]*****}****** ****, ************, *** **** ******* | ***** ***** ** {[*-(*-************)-*-***************-*-********]*****}****** ****, ************, *** **** ******* | ***** ***** ** {[*-(*-************)-*-***************-*-********]*****}****** ****, ************, *** **** ******* | ***** ***** ** {[*-(*-************)-*-***************-*-********]*****}****** ****, ************, *** **** ******* | ************ *** ******* *** ******** ****** | ************ *** ******* *** ******** ****** | ************ *** ******* *** ******** ****** | ****** *********** ********** *** ******* ** *** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|